{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:15:01Z","timestamp":1784304901383,"version":"3.55.0"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1009395","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000}}],"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PID2019-110344RB-I00"],"award-info":[{"award-number":["PID2019-110344RB-I00"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["PIBA_2020_01_0055"],"award-info":[{"award-number":["PIBA_2020_01_0055"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005004","name":"Ekonomiaren Garapen eta Lehiakortasun Saila, Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["KK-2020\/00008"],"award-info":[{"award-number":["KK-2020\/00008"]}],"id":[{"id":"10.13039\/501100005004","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Fundaci\u00f3n Ram\u00f3n Areces","doi-asserted-by":"publisher","award":["PREMAMM"],"award-info":[{"award-number":["PREMAMM"]}],"id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/02024, PI17\/00701, PI19\/01352, PI20\/01306"],"award-info":[{"award-number":["PI16\/02024, PI17\/00701, PI19\/01352, PI20\/01306"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014139","name":"CIBERONC","doi-asserted-by":"crossref","award":["CB16\/12\/00489"],"award-info":[{"award-number":["CB16\/12\/00489"]}],"id":[{"id":"10.13039\/501100014139","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ERANET program ERAPerMed","award":["MEET-AML"],"award-info":[{"award-number":["MEET-AML"]}]},{"name":"MINECO Explora","award":["RTHALMY"],"award-info":[{"award-number":["RTHALMY"]}]},{"name":"Cancer Research UK and AECC under the Accelerator Award Programme","award":["C355\/A26819"],"award-info":[{"award-number":["C355\/A26819"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI17\/00297"],"award-info":[{"award-number":["FI17\/00297"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Synthetic Lethality (SL) is currently defined as a type of genetic interaction in which the loss of function of either of two genes individually has limited effect in cell viability but inactivation of both genes simultaneously leads to cell death. Given the profound genomic aberrations acquired by tumor cells, which can be systematically identified with -omics data, SL is a promising concept in cancer research. In particular, SL has received much attention in the area of cancer metabolism, due to the fact that relevant functional alterations concentrate on key metabolic pathways that promote cellular proliferation. With the extensive prior knowledge about human metabolic networks, a number of computational methods have been developed to predict SL in cancer metabolism, including the genetic Minimal Cut Sets (gMCSs) approach. A major challenge in the application of SL approaches to cancer metabolism is to systematically integrate tumor microenvironment, given that genetic interactions and nutritional availability are interconnected to support proliferation. Here, we propose a more general definition of SL for cancer metabolism that combines genetic and environmental interactions, namely loss of gene functions and absence of nutrients in the environment. We extend our gMCSs approach to determine this new family of metabolic synthetic lethal interactions. A computational and experimental proof-of-concept is presented for predicting the lethality of dihydrofolate reductase (DHFR) inhibition in different environments. Finally, our approach is applied to identify extracellular nutrient dependences of tumor cells, elucidating cholesterol and myo-inositol depletion as potential vulnerabilities in different malignancies.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1009395","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T17:50:53Z","timestamp":1647280253000},"page":"e1009395","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8961-4513","authenticated-orcid":true,"given":"I\u00f1igo","family":"Apaolaza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edurne","family":"San Jos\u00e9-En\u00e9riz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3769-5419","authenticated-orcid":true,"given":"Luis V.","family":"Valcarcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xabier","family":"Agirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6115-8790","authenticated-orcid":true,"given":"Felipe","family":"Prosper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1155-3105","authenticated-orcid":true,"given":"Francisco J.","family":"Planes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"key":"pcbi.1009395.ref001","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41591-019-0414-6","article-title":"A longitudinal big data approach for precision health","volume":"25","author":"SM Schussler-Fiorenza Rose","year":"2019","journal-title":"Nat Med"},{"key":"pcbi.1009395.ref002","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJMe0903044","article-title":"Synthetic Lethality\u2014A New Direction in Cancer-Drug Development","author":"JD Iglehart","year":"2009","journal-title":"N Engl J Med"},{"key":"pcbi.1009395.ref003","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrclinonc.2010.172","article-title":"Synthetic lethal approaches to breast cancer therapy","volume":"7","author":"FL Rehman","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"pcbi.1009395.ref004","article-title":"Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality","author":"L Jerby-Arnon","year":"2014","journal-title":"Cell"},{"key":"pcbi.1009395.ref005","article-title":"SynLethDB: Synthetic lethality database toward discovery of selective and sensitive anticancer drug targets","author":"J Guo","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"pcbi.1009395.ref006","article-title":"Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening","author":"ER McDonald","year":"2017","journal-title":"Cell"},{"key":"pcbi.1009395.ref007","article-title":"TranscriptAchilles: A genome-wide platform to predict isoform biomarkers of gene essentiality in cancer","author":"F Carazo","year":"2019","journal-title":"Gigascience"},{"key":"pcbi.1009395.ref008","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a Cancer Dependency Map","volume":"170","author":"A Tsherniak","year":"2017","journal-title":"Cell"},{"key":"pcbi.1009395.ref009","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","author":"M Ghandi","year":"2019","journal-title":"Nature"},{"key":"pcbi.1009395.ref010","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bbabio.2016.12.003","article-title":"Metabolic synthetic lethality in cancer therapy","volume":"1858","author":"V Zecchini","year":"2017","journal-title":"Biochim Biophys Acta\u2014Bioenerg"},{"key":"pcbi.1009395.ref011","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature10363","article-title":"Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase","volume":"477","author":"C Frezza","year":"2011","journal-title":"Nature"},{"key":"pcbi.1009395.ref012","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/ncb3233","article-title":"Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis","volume":"17","author":"S Cardaci","year":"2015","journal-title":"Nat Cell Biol"},{"key":"pcbi.1009395.ref013","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.18632\/oncotarget.23639","article-title":"Characterization and metabolic synthetic lethal testing in a new model of SDH-loss familial pheochromocytoma and paraganglioma","volume":"9","author":"J Smestad","year":"2018","journal-title":"Oncotarget"},{"key":"pcbi.1009395.ref014","first-page":"8","article-title":"An in-silico approach to predict and exploit synthetic lethality in cancer metabolism","author":"I Apaolaza","year":"2017","journal-title":"Nat Commun"},{"key":"pcbi.1009395.ref015","article-title":"Recon3D enables a three-dimensional view of gene variation in human metabolism","author":"E Brunk","year":"2018","journal-title":"Nat Biotechnol"},{"key":"pcbi.1009395.ref016","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrg.2017.74","article-title":"Emerging and evolving concepts in gene essentiality","volume":"19","author":"G Rancati","year":"2018","journal-title":"Nat Rev Genet"},{"key":"pcbi.1009395.ref017","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cell.2016.08.057","article-title":"Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia","volume":"167","author":"DB Sykes","year":"2016","journal-title":"Cell"},{"key":"pcbi.1009395.ref018","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41591-019-0404-8","article-title":"The landscape of cancer cell line metabolism","volume":"25","author":"H Li","year":"2019","journal-title":"Nat Med"},{"key":"pcbi.1009395.ref019","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.critrevonc.2006.07.009","article-title":"Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia","volume":"61","author":"UK Narta","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"pcbi.1009395.ref020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrd3504","article-title":"Targeting cancer metabolism: a therapeutic window opens","volume":"10","author":"MG Vander Heiden","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"pcbi.1009395.ref021","first-page":"321","article-title":"Creation and analysis of biochemical constraint-based models: the COBRA Toolbox v3.0","volume":"8","author":"L Heirendt","year":"2019","journal-title":"Nat Protoc"},{"key":"pcbi.1009395.ref022","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.chembiol.2017.08.028","article-title":"Targeting Metabolism for Cancer Therapy","volume":"24","author":"A Luengo","year":"2017","journal-title":"Cell Chem Biol"},{"key":"pcbi.1009395.ref023","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.cell.2018.09.041","article-title":"Mitochondrial One-Carbon Pathway Supports Cytosolic Folate Integrity in Cancer Cells","volume":"175","author":"Y Zheng","year":"2018","journal-title":"Cell"},{"key":"pcbi.1009395.ref024","doi-asserted-by":"crossref","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","article-title":"HMDB 4.0: The human metabolome database for 2018","volume":"46","author":"DS Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"pcbi.1009395.ref025","first-page":"945","article-title":"Thymidine and hypoxanthine requirements of normal and malignant human cells for protection against methotrexate cytotoxicity","author":"SB Howell","year":"1981","journal-title":"CANCER RES"},{"key":"pcbi.1009395.ref026","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0014-4827(69)90377-2","article-title":"Nutritional requirements of human leukemic cells. Asparagine requirements and the effect of l-asparaginase","volume":"57","author":"H Lazarus","year":"1969","journal-title":"Exp Cell Res"},{"key":"pcbi.1009395.ref027","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.15252\/embj.201696151","article-title":"Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine","volume":"36","author":"J Zhang","year":"2017","journal-title":"EMBO J"},{"key":"pcbi.1009395.ref028","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1158\/1078-0432.CCR-18-4140","article-title":"MYC-driven small-cell lung cancer is metabolically distinct and vulnerable to arginine depletion","volume":"25","author":"MD Chalishazar","year":"2019","journal-title":"Clin Cancer Res"},{"key":"pcbi.1009395.ref029","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41586-019-0945-5","article-title":"Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death","volume":"567","author":"J Garcia-Bermudez","year":"2019","journal-title":"Nature"},{"key":"pcbi.1009395.ref030","article-title":"SLC5A3-dependent myo-inositol auxotrophy in acute myeloid leukemia. bioRxiv","author":"Y Wei","year":"2020","journal-title":"In vivo genetic screen identifies aCold Spring Harbor Laboratory"},{"key":"pcbi.1009395.ref031","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.cmet.2019.02.001","article-title":"Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer","volume":"29","author":"CJ Halbrook","year":"2019","journal-title":"Cell Metab"},{"key":"pcbi.1009395.ref032","first-page":"962","article-title":"The nutrient environment affects therapy Nutrient availability affects cancer cell metabolism and therapeutic responses","volume":"360","author":"A Muir","year":"2018","journal-title":"Science (80-)"},{"key":"pcbi.1009395.ref033","article-title":"Synthetic Lethality in Cancer Therapeutics: The Next Generation","author":"J Setton","year":"2021","journal-title":"Cancer Discov"},{"key":"pcbi.1009395.ref034","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1182\/blood.2019002132","article-title":"How I treat the toxicities of pegasparaginase in adults with acute lymphoblastic leukemia","volume":"135","author":"I Aldoss","year":"2020","journal-title":"Blood"},{"key":"pcbi.1009395.ref035","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature22056","article-title":"Modulating the therapeutic response of tumours to dietary serine and glycine starvation","volume":"544","author":"ODK Maddocks","year":"2017","journal-title":"Nature"},{"key":"pcbi.1009395.ref036","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ebiom.2019.09.033","article-title":"Metabolomic profiling identifies pathways associated with minimal residual disease in childhood acute lymphoblastic leukaemia","volume":"48","author":"JM Schraw","year":"2019","journal-title":"EBioMedicine"},{"key":"pcbi.1009395.ref037","doi-asserted-by":"crossref","first-page":"e44235","DOI":"10.7554\/eLife.44235","article-title":"Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability","volume":"8","author":"MR Sullivan","year":"2019","journal-title":"Elife"},{"key":"pcbi.1009395.ref038","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1158\/0008-5472.CAN-18-3726","article-title":"The tumor metabolic microenvironment: Lessons from lactate","volume":"79","author":"JC Garc\u00eda-Canaveras","year":"2019","journal-title":"Cancer Res"},{"key":"pcbi.1009395.ref039","first-page":"7","article-title":"In-silico gene essentiality analysis of polyamine biosynthesis reveals APRT as a potential target in cancer","author":"J Pey","year":"2017","journal-title":"Sci Rep"},{"key":"pcbi.1009395.ref040","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jmb.2003.10.005","article-title":"Sub-families of \u03b1\/\u03b2 Barrel Enzymes: A New Adenine Deaminase Family","volume":"334","author":"C Ribard","year":"2003","journal-title":"J Mol Biol"},{"key":"pcbi.1009395.ref041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/msb.2011.51","article-title":"Predicting selective drug targets in cancer through metabolic networks","volume":"7","author":"O Folger","year":"2011","journal-title":"Mol Syst Biol"},{"key":"pcbi.1009395.ref042","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cels.2017.01.010","article-title":"A Systematic Evaluation of Methods for Tailoring Genome-Scale Metabolic Models","volume":"4","author":"S Opdam","year":"2017","journal-title":"Cell Syst"},{"key":"pcbi.1009395.ref043","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/bioinformatics\/bty656","article-title":"gMCS: fast computation of genetic minimal cut sets in large networks","volume":"35","author":"I Apaolaza","year":"2018","journal-title":"Bioinformatics"},{"key":"pcbi.1009395.ref044","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1124\/jpet.113.206672","article-title":"Low-dose methotrexate results in the selective accumulation of aminoimidazole carboxamide ribotide in an erythroblastoid cell line","volume":"347","author":"RS Funk","year":"2013","journal-title":"J Pharmacol Exp Ther"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1009395","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T21:59:11Z","timestamp":1648159151000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009395"}},"subtitle":[],"editor":[{"given":"Nathan E.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1009395","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1009395","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]}}}